Showing results (101-110 of 434) with videos related to

Sort By:
Pageof 44
The Oncologist|May 6, 2022
Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysisAparna R Parikh, Elena Gonzalez-Gugel, Natalia Smolyakova, et al.
Frontiers in Immunology|March 12, 2026
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancerJamie Hur, Massimo Fantini, Lidia Hernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Use of research biopsies in clinical trials: are risks and benefits adequately discussed?Michael J Overman, Janhavi Modak, Scott Kopetz, et al.
Investigational New Drugs|April 19, 2018
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedulesKamalesh Sankhala, Chris H Takimoto, Alain C Mita, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patientsOfer Margalit, Amos Stemmer, William J Chapin, et al.
Journal of Cellular Physiology|May 12, 2006
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinasesMaria Pia Morelli, Tina Cascone, Teresa Troiani, et al.
Anti-Cancer Drugs|November 28, 2017
Integrated safety summary for trifluridine/tipiracil (TAS-102)Alfredo Falcone, Atsushi Ohtsu, Eric Van Cutsem, et al.
Annals of Surgical Oncology|November 7, 2014
Is complete liver resection without resection of synchronous lung metastases justified?Yoshihiro Mise, Scott Kopetz, Reza J Mehran, et al.
Cancers|May 25, 2024
A Gold Standard-Derived Modular Barcoding Approach to Cancer TranscriptomicsYan Zhu, Mohamad Karim I Koleilat, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerRaju Kandimalla, Feng Gao, Takatoshi Matsuyama, et al.
Pageof 44